|
|
Position:
Senior/Principle Scientist (Immunology/Cell Biology)
Employer:
AbVision
Description:
Job Description and Responsibilities:
- Lead R&D projects for commercial success in the area of immunotherapy
- Responsible for designing and executing emerging therapeutic modalities for next generation of therapeutic antibody, vaccine and cell therapy
- Implementation of in vitro functional studies for human and mouse immune cells (T and B cells, DC etc.), and in vivo efficacy animal studies.
- Guide team members to carry out work and input for building product pipelines
- Draft writing for patent and regulatory filings for drug candidates
- Responsible for strategic collaboration and CRO communication worldwide
Qualifications/Experience:
Qualifications/Requirement:
- Ph.D. degree with a minimum of 8 years of related experience in Immunology/cell biology with specific research interests focused on immuno-oncology.
- Experience in working in biotech/pharmaceutical Industry; knowledge in the process of drug discovery and development
- Experience in recombinant virus expression systems, such as adeno-associated viruses (AAV), lentivirus etc.
- Expertise in human immune cell-based functional assays and experimental techniques of immunology, such as human primary cell culture and activation, flow cytometric analysis, cytotoxicity, cytokine assays, etc.
- Familiar with molecular approaches for genetic engineering of immune cells, antibody engineering, and library expression and screening etc.
- Experience in small animal handling and animal models are a plus.
- Strong problem-solving skills and able to design and advance project independently.
- Work proactively to resolve issues. A good team player and management skills.
- Able to adapt a fast-paced environment. "Do what it takes" attitude and highly motivated.
Location:
Milpitas
Contact:
Send resumes with salary requirements to chengchic@abvisioninc.com, referencing the job code: 05062020CC.
Post Date:
5/15/2020 12:00:00 AM
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
Lena Biosciences
Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
|
Lena Biosciences
Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
|
Alturas Analytics, Inc.
Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
|
Submit a Text Ad
|